How MD was paid
$1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| John Alam, MDPresident & Chief Executive Officer | $614,800 | $94,680 | $338,140 | $0 | $1,047,620 |
| William ElderChief Financial Officer, General Counsel & Corporate Secretary | $467,100 | $42,606 | $176,564 | $0 | $686,270 |
| Kelly Blackburn, MHAExec. Vice President, Clinical Development | $436,555 | $42,606 | $161,784 | $11,600 | $652,545 |
| Robert J. Cobuzzi, Jr., PhDFormer Chief Operating Officer | $238,551 | $42,606 | — | $636,376 | $917,533 |
What changed and why
- $1MCEO total compensation increased slightly to $1,047,620 in fiscal 2025 from $1,036,352 in fiscal 2024.
- $615KDr. John Alam received a base salary of $614,800 and non-equity incentive compensation of $338,140 for 2025.
- $636KFormer COO Dr. Robert J. Cobuzzi, Jr. received $636,376 in all other compensation related to his separation agreement.
- Executive cash bonuses are determined annually based on performance goals like clinical trial progress and financial health.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.